IRIS UniCatt

Tursi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 686
NA - Nord America 606
EU - Europa 477
SA - Sud America 196
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 574
SG - Singapore 340
CN - Cina 166
BR - Brasile 147
IT - Italia 110
DE - Germania 82
SE - Svezia 62
FR - Francia 55
VN - Vietnam 44
GB - Regno Unito 37
IE - Irlanda 29
FI - Finlandia 27
ID - Indonesia 27
KR - Corea 22
CA - Canada 20
IN - India 20
AR - Argentina 18
PL - Polonia 14
UA - Ucraina 14
BD - Bangladesh 12
CO - Colombia 11
HK - Hong Kong 11
JP - Giappone 11
RU - Federazione Russa 11
EC - Ecuador 10
ES - Italia 8
MX - Messico 7
BE - Belgio 6
NL - Olanda 5
PK - Pakistan 5
SA - Arabia Saudita 5
AT - Austria 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
TR - Turchia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EG - Egitto 3
VE - Venezuela 3
DZ - Algeria 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
JM - Giamaica 1
JO - Giordania 1
LI - Liechtenstein 1
MU - Mauritius 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 1.987
Salva come PNG Salva come JPEG
Città #
Singapore 183
Chandler 97
Ashburn 69
Hefei 45
New York 41
Beijing 40
Los Angeles 32
Dublin 27
Frankfurt am Main 27
Milan 24
Munich 23
Jakarta 22
Seoul 22
Ho Chi Minh City 17
Rome 14
Helsinki 13
Marseille 13
Hong Kong 11
Kent 11
Warsaw 11
Boston 10
Brooklyn 10
São Paulo 10
The Dalles 10
Tokyo 10
Nuremberg 9
Bogotá 8
Houston 8
Montreal 8
Turku 8
Hanoi 7
Jacksonville 7
Paris 7
Princeton 7
Pune 7
Boardman 6
Brussels 6
Chicago 6
North Bergen 6
Seattle 6
Toronto 6
Chennai 5
Curitiba 5
Fairfield 5
Poplar 5
Portsmouth 5
Appignano 4
Brasília 4
Dhaka 4
Guarulhos 4
London 4
Madrid 4
Moscow 4
Quito 4
Redwood City 4
Stockholm 4
Wilmington 4
Ann Arbor 3
Baghdad 3
Belo Horizonte 3
Biên Hòa 3
Cairo 3
Campinas 3
Caxias do Sul 3
Chelsea 3
Düsseldorf 3
Florence 3
Hyderabad 3
Johannesburg 3
Lahore 3
Lappeenranta 3
Lauterbourg 3
Manaus 3
Monte Argentario 3
Orem 3
Ribeirão Preto 3
Rio de Janeiro 3
San Diego 3
San Francisco 3
San Mateo 3
Santa Clara 3
Tashkent 3
Verona 3
Washington 3
Algiers 2
Bexley 2
Bremen 2
Brno 2
Buenos Aires 2
Buffalo 2
Busto Arsizio 2
Bắc Giang 2
Campo Grande 2
Cattolica 2
Changsha 2
Denver 2
Edinburgh 2
Falkenstein 2
Fulham 2
Guayaquil 2
Totale 1.086
Salva come PNG Salva come JPEG
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 141
Effect of moderate and heavy alcohol consumption on intestinal transit time 121
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. 109
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care 108
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 96
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease 91
Microbiota Composition in Diverticular Disease: Implications for Therapy 87
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 87
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase 84
Microbiota Composition in Diverticular Disease: Implications for Therapy 82
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 79
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 78
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 78
Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? 73
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 72
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 71
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 69
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 66
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 59
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis 58
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 57
Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 56
Response to Jackson et al 53
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 51
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 47
International Consensus on Diverticulosis and Diverticular Disease. Statements from the 3rd International Symposium on Diverticular Disease 45
Totale 2.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 1 1 0 2 0 3 1
2021/202281 3 2 0 0 1 1 2 4 3 18 23 24
2022/2023237 27 27 11 40 13 25 16 26 19 10 16 7
2023/2024235 9 43 23 17 8 31 21 4 18 22 28 11
2024/2025557 13 10 45 20 46 13 21 19 46 77 139 108
2025/2026813 201 54 108 194 211 45 0 0 0 0 0 0
Totale 2.018